newsMHRA approves Epidyolex® (cannabidiol) for TSC seizure treatment12 August 2021 | By Anna Begley (European Pharmaceutical Review)GW Pharmaceuticals received approval for Epidyolex®(cannabidiol) for the treatment of seizures linked to tuberous sclerosis complex (TSC) in the UK.
articleCarving out a slice of the European medical cannabis market10 February 2021 | By Peter Kohut (Arriello)The European medical cannabis market lacks a common regulatory framework; Peter Kohut charts a route through the complexity and highlights opportunities for the taking.
newsFDA approves Epidyolex for treatment of tuberous sclerosis complex-associated seizures3 August 2020 | By Victoria Rees (European Pharmaceutical Review)Epidyolex, a cannabidiol oral solution, has been given approval by the FDA to treat seizures associated with tuberous sclerosis complex (TSC).
